3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Rectal Neoplasms
1
Radiation Injuries
1
Multiple Myeloma
1
Multiple Chronic Conditions
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hematologic Neoplasms
1
Fatigue
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Breast Neoplasm Female
1
Brain Neoplasms
1
Interventions
Radiosurgery
12
Temozolomide
10
Radiotherapy
10
Magnetic Resonance Spectroscopy
7
Erlotinib Hydrochloride
6
Bevacizumab
6
Surgical Procedures, Operative
5
Pemetrexed
5
Gefitinib
5
Drug Therapy
5
Carboplatin
5
pyrotinib
4
icotinib
4
aumolertinib
4
Trastuzumab
3
Spermine Synthase
3
Radiation
3
Lomustine
3
Etoposide
3
Dexmedetomidine
3
Chlorotoxin
3
Carmustine
3
osimertinib
2
camrelizumab
2
apatinib
2
Tyrosine Kinase Inhibitors
2
Thiotepa
2
Surveys and Questionnaires
2
Sevoflurane
2
Propofol
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Brain Neoplasms
×
Patient Reported Outcome Measures
×
Clear all
NCT04292353
2021-05-05
WP-12
University of Aarhus
Unknown
67 enrolled